{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:41:30Z","timestamp":1788316890633,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020046","name":"Khalifa Bin Zayed Al Nahyan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR180035"],"award-info":[{"award-number":["RR180035"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP240392"],"award-info":[{"award-number":["RP240392"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013778","name":"Appendix Cancer Pseudomyxoma Peritonei Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013778","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015725","name":"Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","esmogastro.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Gastrointestinal Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.esmogo.2025.100133","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T12:37:22Z","timestamp":1738327042000},"page":"100133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and characterization of orthotopic patient-derived xenograft models of peritoneal metastatic mucinous appendiceal adenocarcinoma"],"prefix":"10.1016","volume":"7","author":[{"given":"I.","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.K.","family":"Pattalachinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.G.","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Fanaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.B.","family":"Gunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.R.","family":"Salle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Zeineddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.A.","family":"Helmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.W.","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.G.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.F.","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.W.","family":"Fowlkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.esmogo.2025.100133_bib1","first-page":"145","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100133_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.16161","article-title":"Efficacy of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma: a randomized crossover trial","volume":"6","author":"Shen","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.esmogo.2025.100133_bib3","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221112478","article-title":"The role of chemotherapy in the treatment of advanced appendiceal cancers: summary of the literature and future directions","volume":"14","author":"Strach","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100133_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02053933","article-title":"Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"36","author":"Sugarbaker","year":"1993","journal-title":"Dis Colon Rectum"},{"issue":"13","key":"10.1016\/j.esmogo.2025.100133_bib5","doi-asserted-by":"crossref","first-page":"10786","DOI":"10.18632\/oncotarget.3198","article-title":"Global gene expression in pseudomyxoma peritonei, with parallel development of two immortalized cell lines","volume":"6","author":"Roberts","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100133_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s13577-023-01015-0","article-title":"Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells","volume":"37","author":"Noguchi","year":"2024","journal-title":"Hum Cell"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100133_bib7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.humpath.2009.12.013","article-title":"Exploring the peritoneal surface malignancy phenotype\u2014a pilot immunohistochemical study of human pseudomyxoma peritonei and derived animal models","volume":"41","author":"Flatmark","year":"2010","journal-title":"Human Pathol"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100133_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100793","article-title":"Experimental treatment of mucinous peritoneal metastases using patient-derived xenograft models","volume":"13","author":"Fleten","year":"2020","journal-title":"Transl Oncol"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100133_bib9","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/cam4.640","article-title":"Patient-derived xenograft mouse models of pseudomyxoma peritonei recapitulate the human inflammatory tumor microenvironment","volume":"5","author":"Kuracha","year":"2016","journal-title":"Cancer Med"},{"issue":"19","key":"10.1016\/j.esmogo.2025.100133_bib12","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.1158\/0008-5472.CAN-23-0013","article-title":"Intraperitoneal paclitaxel is a safe and effective therapeutic strategy for treating mucinous appendiceal adenocarcinoma","volume":"83","author":"Ito","year":"2023","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100133_bib13","first-page":"633","article-title":"Accelerated somatic mutation calling for whole-genome and whole-exome sequencing data from heterogenous tumor samples","volume":"34","author":"Ji","year":"2024","journal-title":"Genome Res"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100133_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13059-016-1029-6","article-title":"MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data","volume":"17","author":"Fan","year":"2016","journal-title":"Genome Biol"},{"issue":"3","key":"10.1016\/j.esmogo.2025.100133_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100133_bib16","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat Methods"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100133_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1541-7786.MCR-23-0749","article-title":"Peritoneal microenvironment promotes appendiceal adenocarcinoma growth: a multi-omics approach using patient-derived xenografts","volume":"22","author":"Pattalachinti","year":"2024","journal-title":"Mol Cancer Res"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100133_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100133_bib19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100133_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"LIMMA powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Research"},{"issue":"6","key":"10.1016\/j.esmogo.2025.100133_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/bioinformatics\/btr671","article-title":"A\u00a0novel significance score for gene selection and ranking","volume":"30","author":"Xiao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.esmogo.2025.100133_bib23","article-title":"Fast gene set enrichment analysis","author":"Korotkevich","year":"2019","journal-title":"bioRxiv. 2019"},{"key":"10.1016\/j.esmogo.2025.100133_bib24","article-title":"Genomic landscape of appendiceal neoplasms","volume":"2","author":"Ang","year":"2018","journal-title":"JCO Precis Oncol"},{"issue":"D1","key":"10.1016\/j.esmogo.2025.100133_bib25","doi-asserted-by":"crossref","first-page":"D1003","DOI":"10.1093\/nar\/gkac888","article-title":"Genenames.org: the HGNC resources in 2023","volume":"51","author":"Seal","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.esmogo.2025.100133_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1211336","article-title":"IgGFc-binding protein and MUC2 mucin produced by colonic goblet-like cells spatially interact non-covalently and regulate wound healing","volume":"14","author":"Gorman","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100133_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40880-019-0361-0","article-title":"Mucinous colorectal adenocarcinoma: clinical pathology and treatment options","volume":"39","author":"Luo","year":"2019","journal-title":"Cancer Commun (Lond)"},{"issue":"35","key":"10.1016\/j.esmogo.2025.100133_bib28","doi-asserted-by":"crossref","first-page":"32258","DOI":"10.1074\/jbc.M204862200","article-title":"Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor\/Ras\/Raf\/extracellular signal-regulated kinase cascade and Sp1","volume":"277","author":"Perrais","year":"2002","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.esmogo.2025.100133_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.12717\/DR.2014.18.1.065","article-title":"Polo-like kinases (plks), a key regulator of cell cycle and new potential target for cancer therapy","volume":"18","author":"Lee","year":"2014","journal-title":"Dev Reprod"},{"issue":"7","key":"10.1016\/j.esmogo.2025.100133_bib30","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.3390\/molecules26071981","article-title":"Aurora kinase B inhibition: a potential therapeutic strategy for cancer","volume":"26","author":"Borah","year":"2021","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.esmogo.2025.100133_bib31","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/sj.onc.1210799","article-title":"CDC20, a potential cancer therapeutic target, is negatively regulated by p53","volume":"27","author":"Kidokoro","year":"2008","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.esmogo.2025.100133_bib32","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.3390\/molecules25112614","article-title":"Drug-drug interactions of irinotecan, 5-fluorouracil, folinic acid and oxaliplatin and its activity in colorectal carcinoma treatment","volume":"25","author":"Zoetemelk","year":"2020","journal-title":"Molecules"},{"issue":"19","key":"10.1016\/j.esmogo.2025.100133_bib33","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.3390\/cancers14194812","article-title":"FOLFOXIRI resistance induction and characterization in human colorectal cancer cells","volume":"14","author":"Ramzy","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"30","key":"10.1016\/j.esmogo.2025.100133_bib34","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2217\/fon-2017-0283","article-title":"Eribulin in advanced breast cancer: safety, efficacy and new perspectives","volume":"13","author":"Garrone","year":"2017","journal-title":"Future Oncol"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100133_bib35","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/14740338.2019.1608946","article-title":"The safety of eribulin for the treatment of metastatic breast cancer","volume":"18","author":"Perez-Garcia","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.esmogo.2025.100133_bib36","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2014.03.013","article-title":"A\u00a0clinical update of using albumin as a drug vehicle - a commentary","volume":"190","author":"Kratz","year":"2014","journal-title":"J\u00a0Control Release"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100133_bib37","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1021\/acs.molpharmaceut.1c00046","article-title":"The uniqueness of albumin as a carrier in nanodrug delivery","volume":"18","author":"Spada","year":"2021","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1016\/j.esmogo.2025.100133_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.0260","article-title":"Serum tumor markers and outcomes in patients with appendiceal adenocarcinoma","volume":"7","author":"Yousef","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.esmogo.2025.100133_bib39","article-title":"Automated, high-throughput platform to generate a high-reliability, comprehensive rectal cancer database","volume":"8","author":"Bhutiani","year":"2024","journal-title":"JCO Clin Cancer Inform"},{"issue":"4","key":"10.1016\/j.esmogo.2025.100133_bib40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jamcollsurg.2010.06.011","article-title":"Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: a study of timing and the\u00a0impact of malignant dedifferentiation","volume":"211","author":"Chua","year":"2010","journal-title":"J\u00a0Am Coll Surg"},{"issue":"5","key":"10.1016\/j.esmogo.2025.100133_bib41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2011.02.002","article-title":"Is malignant dedifferentiation for mucinous appendiceal neoplasms a valid phenomenon or merely histopathologic ambiguity?","volume":"212","author":"Raghav","year":"2011","journal-title":"J\u00a0Am Coll Surg"},{"issue":"8","key":"10.1016\/j.esmogo.2025.100133_bib42","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41379-019-0256-2","article-title":"Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants","volume":"32","author":"LaFramboise","year":"2019","journal-title":"Mod Pathol"},{"issue":"30","key":"10.1016\/j.esmogo.2025.100133_bib43","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1038\/onc.2008.55","article-title":"A\u00a0role for Myc in facilitating transcription activation by E2F1","volume":"27","author":"Leung","year":"2008","journal-title":"Oncogene"},{"issue":"42","key":"10.1016\/j.esmogo.2025.100133_bib44","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1038\/sj.onc.1205828","article-title":"E2F activity is essential for survival of Myc-overexpressing human cancer cells","volume":"21","author":"Santoni-Rugiu","year":"2002","journal-title":"Oncogene"}],"container-title":["ESMO Gastrointestinal Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949819825000020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:00:02Z","timestamp":1778936402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949819825000020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":41,"alternative-id":["S2949819825000020"],"URL":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100133","relation":{},"ISSN":["2949-8198"],"issn-type":[{"value":"2949-8198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of orthotopic patient-derived xenograft models of peritoneal metastatic mucinous appendiceal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"ESMO Gastrointestinal Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmogo.2025.100133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100133"}}